Ticker Scorecard - BGNE Basics Company: BeiGene, Ltd. IPO Date: February 1, 2016 Sector: Healthcare Industry: Biotech Market Cap: $19.34B Activated in VL: False Average Daily Range Avg Daily Range: $3.48 | 2.15% Avg Daily Range (30 D): $2.56 | 1.32% Avg Daily Range (90 D): $2.50 | 1.21% Institutional Daily Volume Avg Daily Volume: .24M Avg Daily Volume (30 D): .23M Avg Daily Volume (90 D): .25M Trade Size Avg Trade Size (Sh.): 58 Avg Trade Size (Sh.) (30 D): 42 Avg Trade Size (Sh.) (90 D): 42 Institutional Trades Total Inst.Trades: 2,209 Avg Inst. Trade: $5.65M Avg Inst. Trade (30 D): $11.11M Avg Inst. Trade (90 D): $7.78M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $5.73M Avg Closing Trade (30 D): $4.68M Avg Closing Trade (90 D): $4.88M Avg Closing Volume: 29.73K     News Feb 3, 2025 @ 9:52 AM Orphan Designated Drugs Market Analysis: Key Trend... Source: Na Dec 15, 2024 @ 2:15 PM Super Micro Computer, Adobe And Nucor Are Among To... Source: Lekha Gupta Dec 9, 2024 @ 12:10 PM Cancer Monoclonal Antibodies Market to Grow at a 1... Source: Globe Newswire Nov 7, 2024 @ 1:00 PM Indaptus Therapeutics Presents Encouraging Interim... Source: N/A Oct 29, 2024 @ 10:00 AM Zymeworks Announces Participation in Upcoming Inve... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.63 $-.09 $-.09 Diluted EPS $-.63 $-.09 $-.09 Revenue $ 3.32B $ 1B $ 929.17M Gross Profit $ 2.78B $ 831.14M $ 791.03M Net Income / Loss $ -860.46M $ -121.35M $ -120.41M Operating Income / Loss $ -872.57M $ -120.27M $ -107.16M Cost of Revenue $ 539.36M $ 170.46M $ 138.13M Net Cash Flow $ -367.46M $ 95.5M $ -189.51M PE Ratio